Skip to content

The clinical value of treatment of back orthosis combined with osteoporotic vertebral fracture

The clinical value of treatment of back orthosis combined with osteoporotic vertebral fracture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037840
Enrollment
Unknown
Registered
2020-09-02
Start date
2020-08-31
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

experimental group :Drug+Spinomed

Sponsors

Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 50-80 years (including 50 and 80 years old) who can walk independently; 2. The whole spine lateral film of the patient showed compression fracture of thoracolumbar (below 6 thoracic) segment with kyphosis. The BMD absolute value of lumbar spine (L1-L4) or total hip is consistent with: - t value = 10 degrees; 4. Patients receiving anti osteoporosis treatment (including physical therapy and drug therapy); 5. Patients who voluntarily received brace therapy.

Exclusion criteria

Exclusion criteria: 1. Patients with bone and metabolic diseases: various metabolic bone diseases, such as osteomalacia or osteogenesis imperfecta, which may interfere with the interpretation of research findings; Paget's disease; Cushing's syndrome; hyperprolactinemia; 2; 2. Patients with various immune system diseases who are using glucocorticoids; 3. Patients with Parkinson's disease which affect balance function; 4. Non operative treatment of new vertebral fracture time < 6 weeks; 5. Whole body: various laboratory examination abnormalities, which the researchers think will hinder the subjects from completing the study or interfere with the interpretation of the research results; 6. Abnormal liver and kidney function affected the drug treatment.

Design outcomes

Primary

MeasureTime frame
angle of kyphosis;VAS score;balance ability;life quality score;

Secondary

MeasureTime frame
re-fracture rate;BMD change rate;

Countries

China

Contacts

Public ContactHua Lin

Nanjing Drum Tower Hospital

lh2116@126.com+86 25-83106666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026